Barely Significant
← all excerpts

Bufalin inhibits hepatocellular carcinoma progression by blocking EGFR-mediated RAS-RAF-MEK-ERK pathway activation.

J Exp Clin Cancer Res · 2025 · PMC12395921 · PMID 40883741

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

did not reach statistical significanceP > 0.05actually significant
Although these differences did not reach statistical significance (all P > 0.05), the consistent numerical superiority of combination therapy across all timepoints suggests a potential prognostic benefit associated with Cinobufacini supplementation.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.